Company intelligence / Profile preview

PainChek

Sydney, New South Wales, Australiapainchek.com ↗

Ownership: Private
Development stage: Other

Overview

The company’s AI-powered app has been clinically validated and regulatory cleared for use in multiple countries. It has enabled over 8.8 million digital pain assessments across more than 1,800 aged care facilities globally. Clinical studies demonstrate improved accuracy and consistency in pain detection for people unable to self-report, leading to better outcomes such as reduced inappropriate psychotropic medication use.

Therapeutic areas: NeurologyOther
Modalities: DeviceArtificial intelligence-based softwareNon-pharmacological therapy (assessment tool)
Industry: Digital Health Medical Devices

Partnerships

InterSystems – Integration with global EMR/EHR platforms for hospitals worldwide

Beyond the preview

Go deeper on PainChek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PainChek.

Explore the full profile